In an endeavor directed towards the construction of the oxabicyclic[3.2.1]octane segment present in the bioactive natural products of cortistatins and icetexanes genre, the title compound, C 13 H 19 BrO 3 , was synthesized from (4aR,9aS)-1, 3,4,4a,5,6,9,9a-octahydrospiro[benzo[7] annulene-2,2 0 -[1,3]dioxolane]-4a-ol via a transannular bromo-etherification protocol. The six-membered ring adopts a twist-boat conformation, while the fused cycloheptane ring adopts a chair conformation. The crystal packing is effected through two distinct intermolecular C-HÁ Á ÁO hydrogen-bond patterns and molecules are arranged to define an interesting motif along the b axis.
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Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz þ 1; (ii) x; Ày þ 1 2 ; z þ 1 2 .
Data collection: APEX2 (Bruker, 2008) ; cell refinement: SAINT (Bruker, 2008) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL.
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Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: DS2204). Mehta, G. & Yaragorla, S. (2011 ). Tetrahedron Lett. 52, 4485-4489. Sheldrick, G. M. (2008 . Acta Cryst. A64, 112-122. Uchiyama, N., Kabututu, Z., Kubata, B. K., Kiuchi, F., Ito, M., Nakajima-Shimada, J., Aoki, T., Ohkubo, K., Fukuzumi, S., Martin, S. K., Honda, G. & Urade, Y. (2005) . Antimicrob. Agents Chemother. 49, 5123-5126. Watanabe, Y., Aoki, S., Tanabe, D., Setiawan, A. & Kobayashi, M. (2007) . Esquivel et al., 1995 & Uchiyama et al., 2005 and cortistatin family ( Fig. 1 ; Aoki et al., 2006 , 2007 & Watanabe et al., 2007 . In particular, cortistatin A and its structural siblings isolated in trace amounts by Kobayashi & coworkers from an Indonesian marine sponge corticium simplex were shown to possess novel architecture and exhibited potent and promising anti-angiogenic activity (Zhao, 2010) and were effective in treating blindness (Czako et al., 2009) , thereby triggering interest to devise tactics for their total synthesis and diversity creation. These attributes of cortistatins encouraged us to devise a strategy to gain rapid access to the oxatricyclic ABC core present in cortistatins.
Several synthetic approaches to cortistatins have been reported utilizing ring-expansion approach, oxidative dearomatization, electrocyclization, 1,3-dipolar cycloaddition/electrocyclization cascade, transannular [4 + 3] cycloaddition, classical Michael/aldol condensation cascade cyclization as the key strategic steps to access the oxatricyclic segment (Hardin Narayan et al., 2010) . However, the present strategy employs a stepwise transannular bromoetherification sequence (Mehta & Sen, 2010; Mehta & Yaragorla, 2011 ) on a readily accessible bicyclic compound obtained via RCM ( Fig. 2 ; Mehta & Likhite, 2008 .
A two step transannular bromoetherification protocol on 7 furnished the title compound 3 (Fig. 2) as the major product corresponding to the oxatricyclic core present in icetexanes along with a minor regioisomeric compound 4 representing the oxatricyclic segment present in cortistatins.
The title compound 3 was crystallized from ethylacetate-hexane(1:1) and the structure was solved and refined in monoclinic P2 1 /c space group with one molecule of 3 in the asymmetric unit. An ORTEP diagram of 3 drawn at 30% ellipsoidal probability is depicted in Fig 3. From the packing diagram it can be seen that the centrosymmetric molecules are connected by weak C11-H11···O2 (2.53 Å, 156°) hydrogen bonds forming a dimeric motif and these dimeric units are further connected by C1-H1···O1 (2.57 Å, 153°)) hydrogen bonds, three dimensionally (Fig. 4) .These two hydrogen bond patterns link the molecules to define an interesting motif along the b axis.
Experimental
The synthesis of the title compound 3 as depicted in Fig. 2 emanates from the known 7-(prop-2-en-1-yl)-1,4-dioxaspiro- 
Refinement
All the non-hydrogen atoms were refined anisotropically. Hydrogen atoms on the C atoms were introduced on calculated positions and were included in the refinement riding on their respective parent atoms
Computing details
Data collection: APEX2 (Bruker, 2008) ; cell refinement: SAINT (Bruker, 2008) ; data reduction: SAINT (Bruker, 2008) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).
Figure 1
Representative example of cortistatin family (cortistatin A 1) & icetexane family (salviasperanol 2).
Figure 2
The synthesis of the title compound.
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Figure 3
The molecular structure of the title compound 3, with the atom numbering scheme. Dispalcement ellipsoids for non-H atoms are drawn at 30% probability. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
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